FDA Approves Direct Biologics to Proceed with a Landmark Phase 3 Acute Respiratory Distress Syndrome (ARDS) Trial
AUSTIN, Texas, April 26, 2022 /PRNewswire/ — Direct Biologics, a regenerative biotechnology company with a groundbreaking extracellular vesicle (EV) platform technology, announced today that the FDA has approved the company to proceed with its Phase 3 clinical trial using its investigational EV drug, ExoFlo, to treat Acute Respiratory Distress Syndrome (ARDS) due to Covid-19. Direct […]
NexImmune Announces Preclinical Research Collaboration with Columbia University Irving Medical Center’s Herbert Irving Comprehensive Cancer Center
GAITHERSBURG, Md., April 26, 2022 (GLOBE NEWSWIRE) — NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells, today announced a preclinical research collaboration with Columbia University Irving Medical Center’s (CUIMC) Herbert Irving Comprehensive Cancer Center (HICCC). The […]
Creative Medical Technology Announces Progress in Developing a Reproducible Clinical Grade of the Company’s ImmCelz® Product
PHOENIX, April 20, 2022 /PRNewswire/ — Creative Medical Technology Holdings, Inc. (“Creative Medical Technology” or the “Company”) (NASDAQ: CELZ), a leading commercial stage biotechnology company focused on a regenerative approach to immunotherapy, urology, neurology, and orthopedics, today announced progress in developing a reproducible clinical grade product of ImmCelz®. Multiple clinical experiments were performed in which […]
bit.bio’s Game-Changing Technology for Reprogramming Stem Cells
In this episode of Vital Science, Mark Kotter and his team at bit.bio have an innovative solution to help create consistent and scalable human cells to help researchers study diseases – by “reprogramming” stem cells. Video Transcription: – [Mark Kotter] What’s unique about bit.bio, is not really the use of these pluripotent stem cells, it’s […]
BioRestorative Therapies Announces Selection of 10 Clinical Sites for its Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease
MELVILLE, N.Y.,, April 18, 2022 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ: BRTX), a clinical stage company focused on stem cell-based therapies, today announced that it has selected 10 of its 15 clinical sites for its Phase 2 clinical trial targeting chronic lumbar disc disease. BioRestorative’s Phase 2 trial is a […]
Micro-Scaffolds Help Produce New Tissue From Stem Cells Faster
One of the most exciting and recent advances in tissue engineering and regenerative medicine (TERM) is to combine together multiple micro-size cellularized units, which are able to self-assemble altogether to recreate larger tissue constructs. A team of researchers at Vienna University of Technology have developed a new technique of creating buckyball shaped microscaffolds with a […]
ExCellThera announces new publication showing its ECT-001 cell therapy improves transplant access for all patients
MONTREAL, April 13, 2022 (GLOBE NEWSWIRE) — ExCellThera Inc. (ExCellThera), an advanced clinical-stage biotechnology company delivering molecules and bioengineering solutions to expand and engineer various cell lines for use in next generation cell and gene therapies, announced today the publication of a scientific article entitled “UM171 expansion of cord blood improves donor availability and HLA […]
New Method to Time-Jump Human Skin Cells by 30 Years
Research from the Babraham Institute has developed a method to time-jump human skin cells by thirty years that is turning back the aging clock for cells without losing their specialized function. The researchers have been able to partly restore the function of older cells and rejuvenate the molecular measure of biological age. Overall, this research […]
Third Person with HIV Cured by Stem Cell Transplant
A breakthrough stem cell treatment has likely cured a third person of HIV. The stem cell transplant combined adult stem cells taken from a relative’s blood along with umbilical cord blood that was genetically matched from a cord blood bank. The cord blood contained genetic mutation resistant to HIV which caused the patient’s immune system […]
Neural Development featuring Dr. Agnete Kirkeby on The Stem Cell Podcast
Dr. Daylun James and Dr. Arun Sharma interview Dr. Agnete Kirkeby in this episode of the Stem Cell Podcast where she discusses moving cell therapies for Parkinson’s disease from animal models to clinical trials, modeling neural tube development, and developing stem cell treatments for narcolepsy. Visit stemcellpodcast.com for more great episodes about stem cell research.